menu search

CGEN / Why Shares of Compugen Rose 16.5% on Wednesday

Why Shares of Compugen Rose 16.5% on Wednesday
Market factors and a company announcement helped the stock climb. Read More
Posted: Nov 30 2022, 16:49
Author Name: The Motley Fool
Views: 112048

CGEN News  

These Israeli pharmaceutical stocks are down in the wake of Hamas attack

By Market Watch
October 9, 2023

These Israeli pharmaceutical stocks are down in the wake of Hamas attack

Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel. more_horizontal

Has Compugen (CGEN) Outpaced Other Medical Stocks This Year?

By Zacks Investment Research
August 29, 2023

Has Compugen (CGEN) Outpaced Other Medical Stocks This Year?

Here is how Compugen (CGEN) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year. more_horizontal

Compugen Ltd. (CGEN) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 15, 2023

Compugen Ltd. (CGEN) Q1 2023 Earnings Call Transcript

Compugen Ltd. (NASDAQ:CGEN ) Q1 2023 Earnings Conference Call May 15, 2023 8:30 AM ET Company Participants Yvonne Naughton - Head of Investor Relation more_horizontal

Why Compugen Shares Are Up Today

By The Motley Fool
February 28, 2023

Why Compugen Shares Are Up Today

The company released its fourth-quarter and full-year results after the bell Monday. more_horizontal

Compugen Ltd. (CGEN) Q4 2022 Earnings Call Transcript

By Seeking Alpha
February 27, 2023

Compugen Ltd. (CGEN) Q4 2022 Earnings Call Transcript

Compugen Ltd. (NASDAQ:CGEN ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Yvonne Naughton - Head, IR and Corpora more_horizontal

Compugen to Release Fourth Quarter and Full Year 2022 Results on Monday, February 27, 2023

By PRNewsWire
February 13, 2023

Compugen to Release Fourth Quarter and Full Year 2022 Results on Monday, February 27, 2023

HOLON, Israel , Feb. 13, 2023 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computation more_horizontal

Why Compugen Stock Got Slammed Today

By The Motley Fool
February 8, 2023

Why Compugen Stock Got Slammed Today

Clinical-stage biotechs are particularly susceptible to shifts in analyst sentiment. more_horizontal

Why Shares of Compugen Rose on Thursday

By The Motley Fool
December 29, 2022

Why Shares of Compugen Rose on Thursday

The clinical-stage biotech retreated a bit from one of its biggest days in a while. more_horizontal


Search within

Pages Search Results: